Alphamab Oncology (9966)
Market Closed
11 Aug, 08:00
HKEX 
8. 55
HKD +0.06
+0.7656%
4.19B Market Cap
- P/E Ratio
- Div Yield
1.37M Volume
- Eps
8.49 HKD
Previous Close Want to track 9966 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alphamab Oncology (9966) Statistics
Valuation metrics
Market Cap 4.19B
Enterprise value 6.53B
Trailing P/E (ttm) -64.06
Forward P/E -
PEG ratio 0.39
Price/Sales (ttm) 11.87
Price/Book (mrq) 3.87
Enterprise Value/Revenue 11.62
Enterprise Value/EBITDA -74.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.03M
Average volume (90 days) 1.68M
Price summary
52-Week low 6.23
52-Week high 15.75
Beta -
50-Day moving average 7.46
200-Day moving average 8.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.2%
Operating margin -0.27%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.41
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 5.67%
Book value per share (mrq) 1.78
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
